C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

CUSIP: 12529R107

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
88,353,400
Total 13F shares
54,715,914
Share change
-9,583,907
Total reported value
$78,242,864
Price per share
$1.43
Number of holders
102
Value change
-$14,672,718
Number of buys
57
Number of sells
70

Quarterly Holders Quick Answers

What is CUSIP 12529R107?
CUSIP 12529R107 identifies CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) as of Q2 2025

As of 30 Jun 2025, C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) was held by 102 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,715,914 shares. The largest 10 holders included WASATCH ADVISORS LP, Lynx1 Capital Management LP, Soleus Capital Management, L.P., ORBIMED ADVISORS LLC, MORGAN STANLEY, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, BlackRock, Inc., Bain Capital Life Sciences Investors, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 101 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.